Literature DB >> 15298172

Identification and characterization of viral antagonists of type I interferon in negative-strand RNA viruses.

A García-Sastre1.   

Abstract

Interferons are cytokines secreted in response to viral infections with potent antiviral activity, and they represent a critical component of the innate immune response against viruses. It has now become apparent that many viruses have evolved different mechanisms to counteract the interferon response, allowing their efficient replication and propagation in their hosts. This review discusses how the development of reverse genetics techniques and the increase in our knowledge of the interferon response have led to the discovery of interferon-antagonistic functions of different genes of viruses belonging to the negative-strand RNA virus group. In many cases, these viral genes encode accessory pro- teins that are not required for viral infectivity but are critical for optimal replication and for virulence in the host.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298172     DOI: 10.1007/978-3-662-06099-5_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  34 in total

1.  NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response.

Authors:  Zhongfang Wang; Nicole C Robb; Eva Lenz; Thorsten Wolff; Ervin Fodor; Stephan Pleschka
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Viral targeting of the interferon-{beta}-inducing Traf family member-associated NF-{kappa}B activator (TANK)-binding kinase-1.

Authors:  Gunhild Unterstab; Stephan Ludwig; Aline Anton; Oliver Planz; Bianca Dauber; Daniel Krappmann; Gudrun Heins; Christina Ehrhardt; Thorsten Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

Review 3.  Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses.

Authors:  Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses.

Authors:  Friedemann Weber; Valentina Wagner; Simon B Rasmussen; Rune Hartmann; Søren R Paludan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 5.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

6.  Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.

Authors:  Christina Ehrhardt; Thorsten Wolff; Stephan Pleschka; Oliver Planz; Wiebke Beermann; Johannes G Bode; Mirco Schmolke; Stephan Ludwig
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector.

Authors:  Luis Martinez-Sobrido; Negin Gitiban; Ana Fernandez-Sesma; Jerome Cros; Sara E Mertz; Nancy A Jewell; Sue Hammond; Emilio Flano; Russell K Durbin; Adolfo García-Sastre; Joan E Durbin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses.

Authors:  Christina Ehrhardt; Thorsten Wolff; Stephan Ludwig
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Antiviral-activated dendritic cells: a paracrine-induced response state.

Authors:  Antonio V Bordería; Boris M Hartmann; Ana Fernandez-Sesma; Thomas M Moran; Stuart C Sealfon
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Tumor necrosis factor alpha enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression.

Authors:  Sampsa Matikainen; Jukka Sirén; Jorma Tissari; Ville Veckman; Jaana Pirhonen; Martina Severa; Qiang Sun; Rongtuan Lin; Seppo Meri; Gilles Uzé; John Hiscott; Ilkka Julkunen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.